Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Linear Formula:
CaCO3
CAS Number:
Molecular Weight:
100.09
EC Number:
207-439-9
UNSPSC Code:
12352302
PubChem Substance ID:
Beilstein/REAXYS Number:
8008338
MDL number:
grade
SAJ first grade
assay
≥98.0%
form
powder
availability
available only in Japan
pH
8
density
2.93 g/mL at 25 °C (lit.)
SMILES string
[Ca++].[O-]C([O-])=O
InChI
1S/CH2O3.Ca/c2-1(3)4;/h(H2,2,3,4);/q;+2/p-2
InChI key
VTYYLEPIZMXCLO-UHFFFAOYSA-L
Still not finding the right product?
Explore all of our products under Calcium carbonate
Storage Class
13 - Non Combustible Solids
wgk
nwg
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Gloves
Regulatory Listings
Regulatory Listings are mainly provided for chemical products. Only limited information can be provided here for non-chemical products. No entry means none of the components are listed. It is the user’s obligation to ensure the safe and legal use of the product.
05-0490-5-500G-J:
jan
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Sophie A Jamal et al.
Lancet (London, England), 382(9900), 1268-1277 (2013-07-23)
Phosphate binders (calcium-based and calcium-free) are recommended to lower serum phosphate and prevent hyperphosphataemia in patients with chronic kidney disease, but their effects on mortality and cardiovascular outcomes are unknown. We aimed to update our meta-analysis on the effect of
M Azizur Rahman et al.
PloS one, 8(3), e58781-e58781 (2013-03-26)
An organic matrix consisting of a protein-polysaccharide complex is generally accepted as an important medium for the calcification process. While the role this "calcified organic matrix" plays in the calcification process has long been appreciated, the complex mixture of proteins
Jane A Cauley et al.
Journal of women's health (2002), 22(11), 915-929 (2013-10-18)
Clinical outcomes of the Women's Health Initiative (WHI) calcium plus vitamin D supplementation trial have been reported during 7.0 years of active intervention. We now report outcomes 4.9 years after the intervention stopped and cumulative findings. Postmenopausal women (N=36,282) were